Structure-activity relationship of nuclear receptor-ligand interactions
- PMID: 14683516
- DOI: 10.2174/1568026033451736
Structure-activity relationship of nuclear receptor-ligand interactions
Abstract
Small molecules such as retinoids, steroid hormones, fatty acids, cholesterol metabolites, or xenobiotics are involved in the regulation of numerous physiological and patho-physiological processes by binding to and controlling the activity of members of the nuclear receptor (NR) superfamily of transcription factors. In addition to natural ligands, synthetic agonists or antagonists have been identified that in some cases specifically target NR isotypes, or elicit tissue-, signaling pathway-, or promoter-selective transcriptional responses. For these ligands the term "selective NR modulators" (SNRMs) has been introduced. Structure determination of apo- and holo-NR ligand-binding domains (LBDs)--some of them complexed to small coactivator or corepressor fragments--revealed the major principles of ligand-dependent NR action and determinants of (isotype-) selective ligand binding. These studies also stimulated the interpretation of tissue-specific effects of SNRMs on wild-type or mutant receptors. In contrast to the increasing knowledge on the structure-activity relationship of NRs with known SNRMs, rather basic questions remain about the regulation of orphan NRs (for which no ligands are known) or "adopted" orphan NRs (for which only recently ligands were identified). Several crystal structures of orphan NR LBDs uncovered unexpected properties, contributed to the understanding of orphan NR function, and may in the future permit the identification or design of ligands. This review will (i) focus on the current understanding of the structure-activity relationship of NR-ligand interactions, (ii) discuss recent advances in the field of "orphan" NR crystallography, and (iii) outline future challenges in NR structural biology.
Similar articles
-
Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):127-37. doi: 10.1016/j.jsbmb.2005.01.004. Epub 2005 Feb 19. J Steroid Biochem Mol Biol. 2005. PMID: 15860255 Review.
-
Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein.Mol Endocrinol. 2005 Sep;19(9):2258-72. doi: 10.1210/me.2004-0534. Epub 2005 May 19. Mol Endocrinol. 2005. PMID: 15905360
-
Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.Mol Endocrinol. 2000 May;14(5):700-17. doi: 10.1210/mend.14.5.0444. Mol Endocrinol. 2000. PMID: 10809233
-
The nuclear receptor ligand-binding domain: a family-based structure analysis.Curr Med Chem. 2005;12(9):1001-16. doi: 10.2174/0929867053764699. Curr Med Chem. 2005. PMID: 15892635
-
Molecular mechanisms of retinoid action.Cell Mol Biol Lett. 2001;6(1):3-52. Cell Mol Biol Lett. 2001. PMID: 11544629 Review.
Cited by
-
Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA.Nature. 2008 Nov 20;456(7220):350-6. doi: 10.1038/nature07413. Nature. 2008. PMID: 19043829 Free PMC article.
-
Nuclear receptors and their selective pharmacologic modulators.Pharmacol Rev. 2013 Mar 1;65(2):710-78. doi: 10.1124/pr.112.006833. Print 2013 Apr. Pharmacol Rev. 2013. PMID: 23457206 Free PMC article. Review.
-
The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation.J Biol Chem. 2009 Jul 17;284(29):19572-9. doi: 10.1074/jbc.M109.007872. Epub 2009 Apr 16. J Biol Chem. 2009. PMID: 19372222 Free PMC article.
-
The potential role of transcription factor aryl hydrocarbon receptor in downregulation of hepatic cytochrome P-450 during sepsis.Int J Mol Med. 2008 Apr;21(4):423-8. Int J Mol Med. 2008. PMID: 18360687 Free PMC article.
-
Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.Endocrinology. 2014 Nov;155(11):4461-72. doi: 10.1210/en.2014-1270. Epub 2014 Jul 22. Endocrinology. 2014. PMID: 25051445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources